Research on the clinical significance of serum procalcitonin in predicting bacteremia

doi:10.3969/j.issn.1673-8640.2014.08.004

Abstract

Abstract: Objective To investigate the relationship of serum procalcitonin (PCT) and bacteremia,and to evaluate the diagnosis significance of serum PCT to predict bacteremia determined by blood cultures. Methods A total of 1 690 patients undergoing blood cultures and PCT were concurrently enrolled for detecting bacteremia by retrospective analysis. The patients were classified into blood culture positive group(129 cases), blood culture negative group(1 463 cases) and contaminated blood culture group(98 cases). According to the difference of PCT concentration, the blood culture positive group was subclassified into 3 groups, gram-negative bacterium group, gram-positive bacterium group and Candida mycoderma group. The difference of PCT concentration in the blood culture positive group was further analyzed comparatively. Results The concentration of PCT in blood culture positive group was higher than those of blood culture negative group and contaminated blood culture group [medians(quartiles) were 2.62(0.37-12.80), 0.17(0.07-0.62) and 0.20(0.09-0.72) ng/mL, P<0.000 1]. In gram-negative bacterium group, Candida mycoderma group and gram-positive bacterium group, the positive rates of serum PCT were 74.5%, 37.5% and 66.7%, respectively, while the PCT concentrations [medians (quartiles) were 6.24(0.43-16.09), 0.47(0.22-3.18) and 1.09(0.24-4.05) ng/mL. PCT concentration in gram-negative bacterium group was higher than those in gram-positive bacterium group and Candida mycoderma group (P<0.05). Conclusions In addition to other clinical parameters, PCT is a reliable parameter for ruling out blood culture contamination and non-bacterial conditions. PCT is effective as a parameter for predicting early bacteremia, and is able to improve the accuracy of diagnosis and avoid the unnecessary antimicrobial usage. PCT has great clinical significance for the clinical diagnosis and treatment.

Key words: Procalcitonin, Bacteremia, Blood culture

CLC Number:

R446.1

HOU Weiwei, XIAO Qianru, JIANG Lian, WAN Haiying. Research on the clinical significance of serum procalcitonin in predicting bacteremia[J]. , 2014, 29(8): 802-805.

References

[1] Jeong S,Park Y,Cho Y, et al. Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture[J]. Clin Chim Acta, 2012,413 (21-22): 1731-1736.
[2] Hall KK, Lyman JA. Updated review of blood culture contamination[J]. Clin Microbiol Rev, 2006,19(4): 788-802.
[3] Schuetz P, Mueller B, Trampuz A. Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative Staphylococci [J]. Infection, 2007, 35(5): 352-355.
[4] Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection[J]. Pediatr Infect Dis J, 2000,19(8): 679-687.
[5] Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection[J]. Intensive Care Med, 2000, 26(9):1193-1200.
[6] Meisner M, Schmidt J, Huttner H, et al. The natural elimination rate of procalcitonin in patients with normal and impaired renal function[J]. Intensive Care Med, 2000, 26(Suppl 2): S212-S216.
[7] Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis[J]. Am J Respir Crit Care Med, 2001, 164(3): 396-402.
[8] Wanner GA, Keel M, Steckholzer U, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients[J]. Crit Care Med, 2000, 28(4): 950-957.
[9] Meisner M, Rauschmayer C, Schmidt J, et al. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications[J]. Intensive Care Med, 2002, 28(8):1094-1102.
[10] Sauerland S, Hensler T, Bouillon B, et al. Plasma levels of procalcitonin and neopterin in multiple trauma patients with or without brain injury[J]. J Neurotrauma, 2003, 20(10): 953-960.
[11] Christ-Crain M, Müller B. Procalcitonin in bacterial infections-hype, hope, more or less[J]. Swiss Med Wkly, 2005,135(31-32): 451-460.
[12] Gogos CA, Drosou E, Bassaris HP, et al. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options[J]. J Infect Dis, 2000, 181(1): 176-180.
[13] Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria[J]. BMC Infect Dis, 2008, 8:38.
[14] Kim MH, Lim G, Kang SY, et al. Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever[J]. Yonsei Med J, 2011, 52(2): 276-281.

[1]	LI Li, SUN Haiyan, LI Yuanrui, DOU Min, TANG Wen, JIANG Limin, SHEN Lisong. Changes and clinical roles of perioperative NT-proBNP and PCT in children with congenital heart disease [J]. Laboratory Medicine, 2023, 38(6): 524-531.
[2]	CHEN Hanlu, WU Shenghai. Influence factors of blood culture negative results and progress of pathogen detection in bloodstream infection [J]. Laboratory Medicine, 2022, 37(7): 688-694.
[3]	ZHAI Shana, SUN Qinghai, YU Yongwu, YE Fang, LIU Maodong. Influence of vancomycin combined with meropenem on serum TNF-α,PCT,IL-6 and peritoneal fluid WBC count in PDRP patients [J]. Laboratory Medicine, 2022, 37(4): 360-364.
[4]	CHU Minjun, LI Xiaojuan, HUANG Hailin, LI Jue, MA Mingbiao, DU Tingyi, WANG Haiping. Influence of delayed entry on fastidious bacterium culture in 2 blood culture systems [J]. Laboratory Medicine, 2022, 37(3): 209-212.
[5]	GU Feng, WU Yanfen, ZHAO Xinhui, HOU Zhaoyuan, WANG Zhihong, QI Hualin. Relationship between procalcitonin level and all-cause death in maintenance hemodialysis patients [J]. Laboratory Medicine, 2022, 37(2): 134-140.
[6]	HE Xuelian, HE Ziyi, LIU Yueyang, YU Yanzhi, ZHANG Siying. Role of line chart model based on peripheral blood-derived inflammation markers in early diagnosis of neonatal septicemia [J]. Laboratory Medicine, 2022, 37(10): 921-927.
[7]	YANG Xi, SONG Wenqi, DONG Fang, MENG Qingying, ZHEN Jinghui, ZHOU Wei. Application of Gram staining and MALDI-TOF MS in the rapid identification of pathogen kinds in children's positive blood culture [J]. Laboratory Medicine, 2022, 37(10): 969-973.
[8]	LI Yanchun, TIAN Bin, YUE Na, HU Zhidong. Analysis for distribution and drug resistance of fungemia pathogen from 2014 to 2020 in a Tianjin hospital [J]. Laboratory Medicine, 2021, 36(8): 800-804.
[9]	YU Jiajia, LI Yuanrui, LIU Ying. MALDI-TOF MS combined with SDS and SAP pretreatment for rapid identification of positive blood culture [J]. Laboratory Medicine, 2021, 36(8): 864-868.
[10]	HOU Weiwei, JIANG Lian, LI Dong. Clinical application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry in the direct detection of blood culture positive specimens [J]. Laboratory Medicine, 2021, 36(4): 424-429.
[11]	QIAO Yuli, HUANG Zongshuai, TIAN Yueru, GUAN Ming, JIANG Xiaofei. Primary exploration of rapid identification and drug sensitivity test of cerebrospinal fluid culture by blood culture enrichment method [J]. Laboratory Medicine, 2021, 36(3): 270-274.
[12]	ZHU Chuanxin, ZHOU Yuping, HE Yan, ZHOU Qin. Diagnostic role of NLR,CRP,PCT,DD and NT-proBNP in severe corona virus disease 2019 [J]. Laboratory Medicine, 2021, 36(2): 190-193.
[13]	PAN Xilong, XU Zhiyuan, XIE Feng, LI Dan. Role of procalcitonin in the diagnosis of different sepsis [J]. Laboratory Medicine, 2021, 36(12): 1215-1218.
[14]	ZHENG Xin, HUANG Qi, XING Shan, TAN Xiaoli, DAI Shuqin, LIU Wanli, LIU Xiaomin. Evaluation of 2 blood cultures' performance with different antibiotic adsorption materials in detecting pathogens on BacT/ALERT system [J]. Laboratory Medicine, 2021, 36(12): 1258-1263.
[15]	ZHU Chuanxin, ZHOU Yuping, ZHOU Qin, ZHOU Guifeng. Early diagnosis value of NLR,PCT and CRP combined determination for COVID-19 [J]. Laboratory Medicine, 2021, 36(1): 53-56.